Association of the eNOS Gene Intron 4 VNTR Polymorphism with Susceptibility to Preeclampsia and Its Severity in an Algerian Cohort
Genes · 2026
DOI: 10.3390/genes17040398 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, 2026. Verfasst von Sara Mimi Atmani und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Cellular and Molecular Biology, Faculty of Biological Sciences, University of Sciences and Technology Houari Boumediene, PB 32, El Alia…. Hauptthemen laut MEDLINE: Pre-Eclampsia, Nitric Oxide Synthase Type III, Minisatellite Repeats, Genetic Predisposition to Disease. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Preeclampsia (PE) is the primary cause of maternal and perinatal morbidity and mortality on a global scale. It is driven by a multifactorial aetiology, in which genetic factors involved in blood pressure regulation, including the endothelial nitric oxide synthase (eNOS) gene, play an important role. This study aimed to investigate the association between eNOS gene polymorphisms and the development and severity of PE in an Algerian cohort.
Methods
A total of 305 Algerian women, comprising 124 patients with PE and 181 healthy controls, were genotyped for two polymorphisms: intron 4 variable number tandem repeat (VNTR) (4a/4b) and the −786 T>C promoter variant. Genotyping was performed using standard polymerase chain reaction (PCR) for VNTR and polymerase chain reaction–restriction fragment length polymorphism (PCR-RFLP) for the −786 T>C variant.
Results
Our results revealed no significant difference in the allelic or genotypic frequencies of the −786 T>C polymorphism between the cases and controls (p > 0.05). Interestingly, the frequency of the protective “4b” allele was significantly lower in cases than in controls (odds ratio (OR) = 0.400 [0.278–0.575]; p < 0.0001). However, the “4a” allele and the 4a/4a genotype were significantly associated with an increased risk of preeclampsia (OR = 2.50 [1.74–3.59], p < 0.0001; and OR = 6.20 [2.85-13.50], p < 0.0001, respectively). Furthermore, they were correlated with disease severity (allelic: OR = 2.76 [1.60–4.75], p = 0.0002; and genotypic: OR = 4.64 [1.83-11.78], p = 0.0003).
Conclusions
These findings support the potential role of the eNOS VNTR 4a/4b polymorphism in both the risk and severity of preeclampsia in the Algerian population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Cellular and Molecular Biology, Faculty of Biological Sciences, University of Sciences and Technology Houari Boumediene, PB 32, El Alia, Bab Ezzouar, Algiers 16111, Algeria.
- Research Laboratory, Biodiversity, Biotechnology, Environment and Sustainable Development, Department of Biology, Faculty of Sciences, M'Hamed Bougara University, Boumerdes 35000, Algeria.
- Department of Obstetrics and Gynaecology, Ibn-Ziri Hospital, EPH Bologhine, Algiers 16000, Algeria.
- Department of Obstetrics and Gynaecology, El-Tayeb Bougasmi Hospital, EPH Zeralda, Algiers 16000, Algeria.
- Faculty of Medicine, University of Algiers 1, Algiers 16000, Algeria.
ORCID-Profile: Sara Mimi Atmani
Zitieren
APA
Atmani, S. M., Bouldjennet, F., Khalili, Y., Feghoul, N., & Dammene Debbih, A. (2026). Association of the eNOS Gene Intron 4 VNTR Polymorphism with Susceptibility to Preeclampsia and Its Severity in an Algerian Cohort. Genes. https://doi.org/10.3390/genes17040398
Vancouver
Atmani SM, Bouldjennet F, Khalili Y, Feghoul N, Dammene Debbih A. Association of the eNOS Gene Intron 4 VNTR Polymorphism with Susceptibility to Preeclampsia and Its Severity in an Algerian Cohort. Genes. 2026. doi:10.3390/genes17040398
BibTeX
@article{Atmani2026,
author = {Atmani, Sara Mimi and Bouldjennet, Faiza and Khalili, Yasmine and Feghoul, Nabyla and Dammene Debbih, Amel},
title = {Association of the eNOS Gene Intron 4 VNTR Polymorphism with Susceptibility to Preeclampsia and Its Severity in an Algerian Cohort},
journal = {Genes},
year = {2026},
doi = {10.3390/genes17040398}
}
EUVIMED